The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $245.72 million. The enterprise value is $442.38 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 126.01 million shares outstanding. The number of shares has decreased by -3.90% in one year.
| Current Share Class | 126.01M |
| Shares Outstanding | 126.01M |
| Shares Change (YoY) | -3.90% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 9.87% |
| Owned by Institutions (%) | 57.42% |
| Float | 80.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.56 |
| Forward PS | 0.82 |
| PB Ratio | 3.97 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.92 |
| P/OCF Ratio | 6.83 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 12.45 |
Financial Position
The company has a current ratio of 7.47, with a Debt / Equity ratio of 12.32.
| Current Ratio | 7.47 |
| Quick Ratio | 6.28 |
| Debt / Equity | 12.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | 15.98 |
| Interest Coverage | -6.36 |
Financial Efficiency
Return on equity (ROE) is -70.44% and return on invested capital (ROIC) is -5.77%.
| Return on Equity (ROE) | -70.44% |
| Return on Assets (ROA) | -5.17% |
| Return on Invested Capital (ROIC) | -5.77% |
| Return on Capital Employed (ROCE) | -10.28% |
| Revenue Per Employee | $419,338 |
| Profits Per Employee | -$50,085 |
| Employee Count | 769 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.73 |
Taxes
In the past 12 months, SKIN has paid $1.10 million in taxes.
| Income Tax | 1.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.56% in the last 52 weeks. The beta is 1.17, so SKIN's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +6.56% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 1.50 |
| Relative Strength Index (RSI) | 68.07 |
| Average Volume (20 Days) | 1,005,011 |
Short Selling Information
The latest short interest is 9.34 million, so 7.41% of the outstanding shares have been sold short.
| Short Interest | 9.34M |
| Short Previous Month | 8.37M |
| Short % of Shares Out | 7.41% |
| Short % of Float | 11.55% |
| Short Ratio (days to cover) | 13.45 |
Income Statement
In the last 12 months, SKIN had revenue of $322.47 million and -$38.52 million in losses. Loss per share was -$0.39.
| Revenue | 322.47M |
| Gross Profit | 182.52M |
| Operating Income | -62.81M |
| Pretax Income | -80.63M |
| Net Income | -38.52M |
| EBITDA | -31.61M |
| EBIT | -62.81M |
| Loss Per Share | -$0.39 |
Full Income StatementBalance Sheet
The company has $371.03 million in cash and $567.69 million in debt, giving a net cash position of -$196.66 million or -$1.56 per share.
| Cash & Cash Equivalents | 371.03M |
| Total Debt | 567.69M |
| Net Cash | -196.66M |
| Net Cash Per Share | -$1.56 |
| Equity (Book Value) | 46.06M |
| Book Value Per Share | 0.37 |
| Working Capital | 406.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $35.98 million and capital expenditures -$457,000, giving a free cash flow of $35.53 million.
| Operating Cash Flow | 35.98M |
| Capital Expenditures | -457,000 |
| Free Cash Flow | 35.53M |
| FCF Per Share | $0.28 |
Full Cash Flow StatementMargins
Gross margin is 56.60%, with operating and profit margins of -19.48% and -11.94%.
| Gross Margin | 56.60% |
| Operating Margin | -19.48% |
| Pretax Margin | -11.60% |
| Profit Margin | -11.94% |
| EBITDA Margin | -9.80% |
| EBIT Margin | -19.48% |
| FCF Margin | 11.02% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.90% |
| Shareholder Yield | 3.90% |
| Earnings Yield | -15.67% |
| FCF Yield | 14.46% |
Analyst Forecast
The average price target for SKIN is $1.42, which is -27.18% lower than the current price. The consensus rating is "Hold".
| Price Target | $1.42 |
| Price Target Difference | -27.18% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 2.52% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of 0.04 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.04 |
| Piotroski F-Score | 5 |